Suppr超能文献

心脏再同步治疗的长期临床结果及左心室导线位置

Long-term clinical outcome and left ventricular lead position in cardiac resynchronization therapy.

作者信息

Kronborg Mads Brix, Albertsen Andi Eie, Nielsen Jens Cosedis, Mortensen Peter Thomas

机构信息

Department of Cardiology, Aarhus University Hospital, Skejby, Bendstrupgaardsvej 100, DK-8200 Aarhus N, Denmark.

出版信息

Europace. 2009 Sep;11(9):1177-82. doi: 10.1093/europace/eup202. Epub 2009 Aug 6.

Abstract

AIMS

To identify the predictive value of a presumed optimal left ventricular lead positions (LV-Ps) on the long-term clinical outcome in patients with cardiac resynchronization therapy (CRT).

METHODS AND RESULTS

Clinical information was collected from patient files in consecutive patients treated with CRT from 1997 to 2007. A presumed optimal LV-Ps were defined as a position between 2 and 5 o'clock in the short-axis circumference and basal or mid-ventricular in the long axis. Symptomatic response was defined as improvement in NYHA class (>or=1) and echocardiographic response as improvement in left ventricular ejection fraction of >or=5% absolute. We included 567 patients [median age 66 years, 453 (80%) male]. The LV-Ps were optimal in 334 (59%) patients. The hazard ratio for all-cause mortality with an optimal LV-Ps was unadjusted 0.79 (0.59-1.06) and adjusted 0.99 (0.71-1.40). The odds ratio (OR) for symptomatic response with an optimal LV-Ps was unadjusted 1.13 (0.79-1.64) and adjusted 1.05 (0.67-1.64), and the OR for echocardiographic response was unadjusted 1.60 (1.02-2.49) and adjusted 1.42 (0.88-2.31).

CONCLUSION

A presumed optimal LV-Ps between 2 and 5 o'clock in the short-axis circumference and basal or mid-ventricular in the long axis is not associated with a lower mortality or a better clinical response in patients treated with CRT.

摘要

目的

确定假定的最佳左心室电极位置(LV-Ps)对心脏再同步治疗(CRT)患者长期临床结局的预测价值。

方法与结果

收集了1997年至2007年接受CRT治疗的连续患者病历中的临床信息。假定的最佳LV-Ps定义为短轴周长2至5点之间且长轴为基底部或心室中部的位置。症状改善定义为纽约心脏协会(NYHA)心功能分级改善(≥1级),超声心动图改善定义为左心室射血分数绝对提高≥5%。我们纳入了567例患者[中位年龄66岁,453例(80%)为男性]。334例(59%)患者的LV-Ps为最佳位置。最佳LV-Ps的全因死亡率未调整风险比为0.79(0.59 - 1.06),调整后为0.99(0.71 - 1.40)。最佳LV-Ps的症状改善优势比(OR)未调整为1.13(0.79 - 1.64),调整后为1.05(0.67 - 1.64),超声心动图改善的OR未调整为1.60(1.02 - 2.49),调整后为1.42(0.88 - 2.31)。

结论

短轴周长2至5点之间且长轴为基底部或心室中部的假定最佳LV-Ps与接受CRT治疗患者的较低死亡率或更好临床反应无关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验